Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Rapid Dose Therapeutics Corp (DOSE.CN)

Rapid Dose Therapeutics Corp (DOSE.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 54,570
  • Shares Outstanding, K 75,791
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta -29.88
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 17.85
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.18
  • Most Recent Earnings -0.04 on 05/31/19
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.620 +14.52%
on 10/10/19
0.750 -5.33%
on 10/15/19
+0.010 (+1.43%)
since 09/18/19
3-Month
0.620 +14.52%
on 10/10/19
0.900 -21.11%
on 07/25/19
-0.060 (-7.79%)
since 07/18/19

Most Recent Stories

More News
Rapid Dose Therapeutics Announces First Closing of Private Placement

Rapid Dose Therapeutics Corp. ("RDT" or the "Corporation") (CSE: DOSE) is pleased to announce that today it has completed the first closing of a private placement of common shares in the capital of the...

DOSE.CN : 0.710 (unch)
Rapid Dose Therapeutics Announces Research Results Published in Frontiers in Pharmacology Journal

Rapid Dose Therapeutics Corp. ("RDT") (CSE: DOSE) announced today that the results of a research study conducted by the University of Nevada, Las Vegas ("UNLV") was published in the high impact journal,...

DOSE.CN : 0.710 (unch)
Rapid Dose Therapeutics Completes Quickstrip(TM) Equipment Installation at Aphria Inc.

Rapid Dose Therapeutics Corp. ("RDT") (CSE: DOSE) announced today that the installation and commissioning of its QuickStrip(TM) production equipment at Aphria Inc. ("Aphria") (TSX: APHA and NYSE: APHA)...

DOSE.CN : 0.710 (unch)
Chemesis International Inc. Provides Update on Rapid Dose

After completing installation, permitting and the testing phase, Chemesis has begun accepting orders of QuickStripOral Thin Strips

CSI.CN : 0.590 (-6.35%)
CADMF : 0.4445 (-5.43%)
DOSE.CN : 0.710 (unch)
Rapid Dose Therapeutics Completes QuickStrip(TM) Equipment Installation in Puerto Rico and Grants Stock Options

Rapid Dose Therapeutics Corp. ("RDT") (CSE: DOSE) announced today that the installation of its QuickStripTMproduction equipment at Chemesis International Inc. ("Chemesis") (CSE: CSI) (OTC: CADMF) (FRA:...

DOSE.CN : 0.710 (unch)
CSI.CN : 0.590 (-6.35%)
CADMF : 0.4445 (-5.43%)
Rapid Dose Therapeutics Commences Clinical Research Trial with GI Research Institute and University of British Columbia

Rapid Dose Therapeutics Corp. (CSE: DOSE), ("RDT") announced today the commencement of a clinical research trial with the GI Research Institute ("GIRI") and the University of British Columbia ("UBC") under...

DOSE.CN : 0.710 (unch)
Rapid Dose Therapeutics Commences Clinical Research Trial with GI Research Institute and University of British Columbia

Rapid Dose Therapeutics Corp. (CSE: DOSE), ("RDT") announced today the commencement of a clinical research trial with the GI Research Institute ("GIRI") and the University of British Columbia ("UBC") under...

DOSE.CN : 0.710 (unch)
Rapid Dose Therapeutics and Thrive Cannabis Sign Manufacturing Agreement for QuickStrip(TM) Cannabis Products

Rapid Dose Therapeutics Corp. (CSE: DOSE), ("RDT") announced today that they have signed a Manufacturing Agreement ("the Agreement") with Thrive Cannabis ("Thrive") to produce QuickStripTM cannabis products...

DOSE.CN : 0.710 (unch)
Rapid Dose Therapeutics Expands Agreement for QuickStrip™ Nutraceutical Product Line in Eastern Europe and Increases Purchase Order to US$4.0 Million

Rapid Dose Therapeutics Corp. (CSE: DOSE), ("RDT") announced today that they have signed an amendment to the 12 month distribution agreement (the "Agreement") with Ukraine Pharma to expand the marketing...

DOSE.CN : 0.710 (unch)
Rapid Dose Reports First Quarter Fiscal 2020 Financial Results and Provides Operations Update

Rapid Dose Therapeutics Corp. ("RDT") (CSE: DOSE) today reported its financial results for the first quarter of fiscal 2020, which ended on May 31, 2019.

DOSE.CN : 0.710 (unch)

Key Turning Points

2nd Resistance Point 0.710
1st Resistance Point 0.710
Last Price 0.710
1st Support Level 0.710
2nd Support Level 0.710

See More

52-Week High 1.330
Fibonacci 61.8% 1.051
Fibonacci 50% 0.965
Fibonacci 38.2% 0.879
Last Price 0.710
52-Week Low 0.600

See More

Business Summary

Rapid Dose Therapeutics Corp is a bio-technology company which, through its subsidiaries, provides proprietary enhanced drug delivery technologies designed to improve patient outcomes. The company through its subsidiary, owns a proprietary oral fast-dissolving drug delivery system, QuickStrip, which...

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar